https://www.selleckchem.com/pr....oducts/dabrafenib-gs
Glioblastoma multiforme (GBM) is the commonest malignant primary brain tumor and still has one of the worst prognoses among cancers in general. There is a need for non-invasive methods to predict individual prognosis in patients with GBM. To evaluate quantitative volumetric tissue assessment of enhancing tumor volume on cranial magnetic resonance imaging (MRI) as an imaging biomarker for predicting overall survival (OS) in patients with GBM. MRI scans of 49 patients with histopathologically confirmed GBM were analyzed retr
Like
Comment
Share
